# Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression

> **NCT05063604** · PHASE2 · TERMINATED · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 40 (actual)

## Conditions studied

- Breast Cancer
- Major Depressive Episode

## Interventions

- **DRUG:** Citalopram
- **BEHAVIORAL:** Psychotherapy

## Key facts

- **NCT ID:** NCT05063604
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-10
- **Primary completion:** 2022-05-10
- **Final completion:** 2022-06-29
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** The CAMAD clinical trial has been terminated due to difficulties in recruiting patients.
- **Last updated:** 2022-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05063604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05063604, "Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05063604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*